TY - JOUR
T1 - Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum
AU - Meyer, Jaimie P.
AU - Moghimi, Yavar
AU - Marcus, Ruthanne
AU - Lim, Joseph K.
AU - Litwin, Alain H.
AU - Altice, Frederick L.
N1 - Funding Information:
Funding for this research was provided through a Bristol Myers-Squibb Virology Fellows Award (JPM) and a Patterson Trust Award in Clinical Research (JPM) and career development grants from the National Institute on Drug Abuse ( K23 DA033858 for JPM, NIMH R25MH83620 for YM and K24 DA017072 for FLA). The funding sources played no role in study design, data collection, analysis, or interpretation, writing of the manuscript, or the decision to submit the paper for publication.
Publisher Copyright:
© 2015 Elsevier B.V.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Background: With the explosion of newly available direct acting antiviral (DAA) Hepatitis C virus (HCV) treatments that demonstrate 95% sustained virologic response (SVR) rates, evidence-based strategies are urgently needed to achieve real-world effectiveness in challenging patient populations. While HIV is incurable, lessons from over 30 years of experience overcoming obstacles to the HIV treatment cascade could be applied to the HCV context. Methods: Using Institute of Medicine guidelines, we conducted a systematic review of published interventions from PubMed, Medline, GoogleScholar, EmBASE, and PsychInfo bibliographic databases and citation indices. Abstracts were first screened by three independent reviewers and studies were included if they involved original research, described a specific intervention, were published in English in a peer-reviewed journal between 2001 and 2014, and had full text available. Results: Evidence-based interventions to enhance HCV assessment, treatment, and adherence generally fell into one of 4 categories, including those involving: (1) diagnosis or case-finding; (2) linkage to HCV care; (3) pre-therapeutic evaluation or treatment initiation; or (4) treatment adherence. While most available eligible studies described interventions using non-contemporary interferon-based HCV treatments, future research will need to address how these interventions apply to the context of well-tolerated, simple, oral treatment regimens. In some cases, we explored how HIV-specific interventions might be modified to fit the HCV spectrum of care engagement. Conclusions: Evidence-based interventions should be strategically incorporated into HCV treatment implementation efforts to most effectively deliver treatment and maximize treatment outcomes.
AB - Background: With the explosion of newly available direct acting antiviral (DAA) Hepatitis C virus (HCV) treatments that demonstrate 95% sustained virologic response (SVR) rates, evidence-based strategies are urgently needed to achieve real-world effectiveness in challenging patient populations. While HIV is incurable, lessons from over 30 years of experience overcoming obstacles to the HIV treatment cascade could be applied to the HCV context. Methods: Using Institute of Medicine guidelines, we conducted a systematic review of published interventions from PubMed, Medline, GoogleScholar, EmBASE, and PsychInfo bibliographic databases and citation indices. Abstracts were first screened by three independent reviewers and studies were included if they involved original research, described a specific intervention, were published in English in a peer-reviewed journal between 2001 and 2014, and had full text available. Results: Evidence-based interventions to enhance HCV assessment, treatment, and adherence generally fell into one of 4 categories, including those involving: (1) diagnosis or case-finding; (2) linkage to HCV care; (3) pre-therapeutic evaluation or treatment initiation; or (4) treatment adherence. While most available eligible studies described interventions using non-contemporary interferon-based HCV treatments, future research will need to address how these interventions apply to the context of well-tolerated, simple, oral treatment regimens. In some cases, we explored how HIV-specific interventions might be modified to fit the HCV spectrum of care engagement. Conclusions: Evidence-based interventions should be strategically incorporated into HCV treatment implementation efforts to most effectively deliver treatment and maximize treatment outcomes.
KW - Care continuum
KW - Hepatitis C
KW - Implementation
KW - Interventions
UR - http://www.scopus.com/inward/record.url?scp=84941807523&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941807523&partnerID=8YFLogxK
U2 - 10.1016/j.drugpo.2015.05.002
DO - 10.1016/j.drugpo.2015.05.002
M3 - Short survey
C2 - 26077144
AN - SCOPUS:84941807523
SN - 0955-3959
VL - 26
SP - 922
EP - 935
JO - International Journal of Drug Policy
JF - International Journal of Drug Policy
IS - 10
ER -